Anti-spike IgG4 and Fc effector responses: The impact of SARS-CoV-2 vaccine platform–specific priming and immune imprinting

作者：Raj Kalkeri, Mingzhu Zhu, Shane Cloney‐Clark, Anand Parekh, Drew Gorinson, Zhaohui Cai, Miranda R. Cai, Soham Mahato, Gordon Chau, Tara M Babu, Anna Wald, Pradhipa Ramanathan, L Carissa Aurelia, Kevin J. Selva, Anthony M. Marchese, Louis Fries, Lisa M. Dunkle, Amy W. Chung, Joyce S. Plested · 发表于：Journal of Infection · 年份：2025 · DOI：10.1016/j.jinf.2025.106543 · 被引用次数：8 · 研究领域：Blood groups and transfusion、Monoclonal and Polyclonal Antibodies Research、Immunodeficiency and Autoimmune Disorders

Proportional increases in anti-Spike (S) IgG4 associated with decreased Fc effector functions have been reported following repeated mRNA, but not recombinant protein-based (rS) (NVX-CoV2373, Novavax, Inc.), SARS-CoV-2 vaccination. We demonstrate the first evidence of a negative correlation between anti-S IgG4 and neutralizing antibody (nAb), as well as antibody-dependent surrogate Fc effector functions. Priming with two NVX-CoV2373 vaccines followed by a third dose was associated with higher IgG1 and IgG3, lower IgG4, higher nAb titers and surrogate Fc effector functions versus mRNA. Immune imprinting of anti-S IgG4 and nAbs, and Fc effector function imprinting after mRNA priming was observed. This effect was partially overcome by updated XBB.1.5 protein subunit vaccination, but not by ancestral vaccine strains. We establish correlation of anti-S IgG4 responses to reduced nAbs and surrogate Fc effector functions and demonstrate the impact of additional booster vaccination on subsequent immune response and Fc effector functions in the context of ancestral and XBB.1.5 strains.